Search clinical trials for: neutralizing antibody

Total 5304 results

Abbott

Approved for marketing

Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis (CanAct)

Rheumatoid Arthritis
Abbott

Approved for marketing

Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab (PROWD)

Rheumatoid Arthritis
Abbott

Completed

Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

Arthritis | Psoriatic
French National Agency for Research on AIDS and...
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

HIV Infections
Medical University of Graz

Completed

Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity

Obesity | Metabolic Syndrome | Insulin Resistance

Austria
National Institute of Allergy and Infectious Diseases...

Completed

Steroids and Methotrexate to Treat Systemic Vasculitis

Inflammation | Vasculitis | Wegener's Granulomatosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Etanercept to Treat Wegener's Granulomatosis

Vasculitis | Wegener's Granulomatosis

United States
National Institute of Arthritis and Musculoskeletal...

Completed

Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis

Dermatomyositis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes

Vasculitis | Wegener's Granulomatosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions

Vasculitis | Wegener's Granulomatosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis

Vasculitis | Wegener's Granulomatosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

United States
National Cancer Institute (NCI)

Completed

A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction

Kidney Diseases

United States
National Institute of Arthritis and Musculoskeletal...

Completed

Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
National Institute of Allergy and Infectious Diseases...

Completed

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

Wegener's Granulomatosis

United States
Renovo

Completed

Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions

Cicatrix

United Kingdom
National Eye Institute (NEI)

Completed

HAT in Eye Complications of Behcet's Disease

Uveitis | Retinal Disease | Behcet's Syndrome

United States
National Institute of Allergy and Infectious Diseases...

Completed

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

Vasculitis | Wegener's Granulomatosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Treatment of Wegener's Granulomatosis With Cyclophosphamide

Vasculitis | Wegener's Granulomatosis

United States
National Cancer Institute (NCI)

Completed

Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac

Lymphoma, T-Cell, Cutaneous | Leukemia, T-Cell

United States
National Cancer Institute (NCI)

Completed

A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab

Stomach Neoplasms | Breast Neoplasms | Lung Neoplasms | Pancreatic Neoplasms | Colonic Neoplasms

United States
National Institute of Allergy and Infectious Diseases...

Completed

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

Acquired Immunodeficiency Syndrome | HIV Infection

United States
National Institute of Diabetes and Digestive and...

Completed

Study Comparing the Safety of BG9588 (Anti-CD40L Antibody) Against Standard Treatment in Kidney Transplantation

Kidney Transplantation

United States
National Institutes of Health Clinical Center (CC)

Completed

Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies

Hepatitis C

United States
National Institute of Allergy and Infectious Diseases...

Completed

Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis

Inflammation | Vasculitis | Wegener's Granulomatosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Daclizumab to Treat Wegener's Granulomatosis

Wegener's Granulomatosis

United States
National Institute of Arthritis and Musculoskeletal...

Completed

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

Lupus Nephritis | Glomerulonephritis, Membranoproliferative

United States
National Institute of Allergy and Infectious Diseases...

Completed

Monoclonal Antibody Treatment of Crohn's Disease

Crohn's Disease

United States
National Institutes of Health Clinical Center (CC)

Completed

Diagnostic Effectiveness of Virtual Bronchoscopy

Chronic Granulomatous Disease | Wegener's Granulomatosis | Job's Syndrome | Bronchogenic Carcinoma | Mycobacterium Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome

Hypereosinophilic Syndrome

United States
National Cancer Institute (NCI)

Completed

Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities

Colorectal Neoplasm

United States
National Institute of Allergy and Infectious Diseases...

Completed

Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography

Lung Diseases | Hypersensitivity | Asthma | Wegener's Granulomatosis

United States
National Institutes of Health Clinical Center (CC)

Completed

Daclizumab to Treat Chronic Immune Thrombocytopenia

Thrombocytopenia

United States
McGill University Health Centre/Research Institute...

Terminated

Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation (Palifermin)

Skin Rash

Canada
Biogen

Completed

Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy (SAFE)

Multiple Sclerosis

Sweden
KU Leuven

Completed

Effect of Anti TNFa Upon Deep Endometriosis Associated Pain (Infliximab)

Endometriosis

Belgium
University of Virginia
National Cancer Institute (NCI)

Terminated

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Lymphoma

United States
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions

Hypertension | Dyslipidemia

Hungary
MedImmune LLC
Cambridge Antibody Technology

Suspended

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
Amgen

Completed

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

Non-Hodgkin's Lymphoma
National Institute of Arthritis and Musculoskeletal...
FDA Office of Orphan Products Development

Completed

Etanercept for Wegener's Granulomatosis

Wegener's Granulomatosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine

Streptococcus Group A

Fiji
Unither Pharmaceuticals

Terminated

Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Ovarian Neoplasms

Canada, United States
Unither Pharmaceuticals

Terminated

A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma

Ovarian Neoplasms

United States
Unither Pharmaceuticals

Terminated

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer

United States
Abbott

Completed

Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

Crohn's Disease

United States
Mount Sinai Hospital, Canada
Pfizer; Canadian Institutes of Health Research (CIHR)

Terminated

Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT (HepASA)

Recurrent Pregnancy Loss | Antiphospholipid Antibody Syndrome

Canada
Assistance Publique - Hôpitaux de Paris

Completed

RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides

Wegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss Syndrome

France
Thrasher Research Fund
Centers for Disease Control and Prevention

Completed

Use of OraQuick for Screening HIV in Children Less Than Eighteen Months Old

HIV Antibody Testing

Zambia

Search clinical trials for: neutralizing antibody

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations